Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythemas associated with essential thrombocythemia

T Tsuji1

  • 1Department of Dermatology, Nagoya City University Medical School, Japan.

The Journal of Dermatology
|October 1, 1995
PubMed
Summary

Essential thrombocythemia (ET) can manifest with skin conditions like erythema. Treatment-induced remission of ET with myelobromitol correlated with the resolution of these associated dermatological symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C.

Digestive diseases and sciences·1992
Same author

Measurement of proliferating cell nuclear antigen (PCNA) and its clinical application in oral cancers.

International journal of oral and maxillofacial surgery·1992
Same author

Suprachiasmal carotid-ophthalmic artery aneurysm--report of two cases.

Neurologia medico-chirurgica·1992
Same author

Histological pancreatitis in end-stage renal disease.

International journal of pancreatology : official journal of the International Association of Pancreatology·1992
Same author

Application of monoclonal antibodies to blood grouping of mixed body fluids.

Nihon hoigaku zasshi = The Japanese journal of legal medicine·1992
Same author

Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.

Chemical & pharmaceutical bulletin·1992

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
  • Skin manifestations can occur in patients with ET, but specific associations require further elucidation.
  • Myelobromitol is a medication used in the management of ET.

Observation:

  • Two distinct cases of erythema are presented in patients with essential thrombocythemia.
  • Case 1 involved a woman who developed erythematous plaques after discontinuing myelobromitol therapy.
  • Case 2 described a man with annular erythemas, unrelated to gallstone surgery, during ET.

Findings:

  • In both reported cases, the erythema resolved when thrombocythemia was brought into remission by myelobromitol.
  • The cessation of myelobromitol in Case 1 was followed by the onset of erythematous plaques.
  • The resolution of erythema in both patients was directly linked to the therapeutic control of ET.

Implications:

  • These cases suggest a potential link between essential thrombocythemia and specific types of erythema.
  • The findings highlight the importance of monitoring dermatological conditions in ET patients undergoing treatment.
  • Further research is warranted to understand the pathomechanisms connecting ET, myelobromitol, and erythema development.

Related Experiment Videos